Stonehage Fleming (UK)’s AbbVie ABBV Stock Holding History

Stonehage Fleming (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$1.66M	Hold	28,100	–	–	0.76%	61
2015 Q3	$1.53M	Sell	28,100 -5,300	-16%	-$345K	0.73%	60
2015 Q2	$2.24M	Hold	33,400	–	–	1.01%	22
2015 Q1	$1.95M	Sell	33,400 -7,600	-19%	-$459K	0.91%	47
2014 Q4	$2.68M	Hold	41,000	–	–	1.32%	14
2014 Q3	$2.37M	Hold	41,000	–	–	1.06%	19
2014 Q2	$2.31M	Hold	41,000	–	–	0.93%	46
2014 Q1	$2.11M	Sell	41,000 -77,700	-65%	-$3.93M	0.89%	42
2013 Q4	$6.27M	Buy	+118,700	New	+$5.83M	2.54%	4

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stonehage Fleming (UK)'s ABBV Position: Q4 2015 in Review

Stonehage Fleming (UK) held its AbbVie (ABBV) position steady in Q4 2015 at 28,100 shares worth $1.66M. The position accounts for 0.76% of the portfolio, ranked #61.

Stonehage Fleming (UK) first reported a position in ABBV in Q4 2013 and has held it in 9 quarters since. The position peaked at $6.27M in Q4 2013. 1,636 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Stonehage Fleming (UK) held 28,100 shares of AbbVie worth $1.66M as of Q4 2015.
Stonehage Fleming (UK) left its AbbVie share count unchanged in Q4 2015.
AbbVie made up 0.76% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #61 holding.
Stonehage Fleming (UK) first reported a position in AbbVie in Q4 2013 and has held it in 9 quarters since.
Stonehage Fleming (UK)'s AbbVie position peaked at $6.27M in Q4 2013.
1,636 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.